Tournament: nano nagle | Round: 2 | Opponent: proof dr | Judge: lukas krause
Rising RandD costs mean that pharma is on the brink of losing monetary incentive to innovate
Gassmann et al 16— Schuhmacher, Alexander, Oliver Gassmann ~Professor of Technology management at University of St. Gallen~, and Markus Hinder. "Changing RandD models in research-based pharmaceutical companies." Journal of translational medicine 14.1 (2016): 1-11. (AG DebateDrills)
The costs for pharmaceutical RandD increased in the past decades significantly. Munos
AND
2002–2011, invested more than USD 5 billion per new drug.
Secondary patents are necessary to incentivize research of both initial active ingredients and follow on innovations, this controls the internal link to all of their innovation impacts—also competitor litigation controls the negative effects well
Foor 21— Meredith Foor; JD candidate at University of New Hampshire; "INCENTIVIZING INNOVATION AND RECLAIMING BALANCE IN THE PHARMACEUTICAL INDUSTRY: A CASE FOR SECONDARY PATENTS"; HeinOnline; May 2021; https://law.unh.edu/sites/default/files/media/2021/05/foor'final.pdf. (AG DebateDrills)
Patents remain a primary focus for the pharmaceutical industry as a means to protect new
AND
a profit, and recycle their profits into new groundbreaking research and innovation.
The follow-on patents also are the only way that we discover miraculous cross-applications of drugs, which is the fastest way to solve emerging disease, which is especially important during a pandemic so it turns and outweighs case on probability
Holman 18—Christopher Holman; Professor of Law at University of Missouri-Kansas City; Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection; Intellectual Property Watch; 9/21/2018; https://www.ip-watch.org/2018/09/21/follow-pharmaceutical-innovations-eligible-patent-protection/. (AG DebateDrills)
The attack on secondary pharmaceutical patents is based in part on the flawed premise that
AND
to the development of drugs as a patent on the active ingredient itself.
Buckland 17 - Danny Buckland (award-winning journalist who writes about health, general features and news, shortlisted for the prestigious Mind Media Awards for his work covering mental health issues), April 26, 2017, "Patents are lifeblood of pharmas", https://www.raconteur.net/legal/intellectual-property/patents-are-lifeblood-of-pharmas/ WJ
Pharmaceutical companies are staffed by ranks of attorneys, and the intellectual property (IP
AND
and innovation. Quite frankly, it would all collapse without good IP."
Biopharmaceutical research is the bedrock of our economy – even minor reductions in income result in mass unemployment and butterfly effects
Sullivan 11 – Thomas Sullivan (Thomas Sullivan is Editor of Policy and Medicine, President of Rockpointe Corporation, founded in 1995 to provide continuing medical education to healthcare professionals around the world. Prior to founding Rockpointe, Thomas worked as a political consultant), July 12, 2011, Study Shows Importance of Biopharmaceutical Jobs For US Economy," Policy and Medicine, http://www.policymed.com/2011/07/study-shows-importance-of-biopharmaceutical-jobs-for-us-economy-for-every-20-billion-loss-in-revenue.html WJ
Biopharmaceutical research companies produce the highest-value jobs, the types of jobs Americans
AND
the biopharmaceutical sector is a key foundation of the life sciences innovation ecosystem.
Howrigon 17 — Ron Howrigon "(President and Founder of Fulcrum Strategies. He earned a Bachelor's degree in Business Administration from Western Michigan University and a Master's in Economics from North Carolina State University, focusing in the area of Health Economics) http://www.kevinmd.com/blog/2017/01/health-care-crash-u-s-economy.html, January 19 2017, WJ
In recent history, the U.S. economy has experienced the near catastrophic
AND
resulting fallout could be could be much worse than even the housing crisis.
Tønnesson 15 Stein Research Professor, Peace Research Institute Oslo; Leader of East Asia Peace program, Uppsala University, 2015, "Deterrence, interdependence and Sino–US peace," International Area Studies Review, Vol. 18, No. 3, p. 297-311
Several recent works on China and Sino–US relations have made substantial contributions to
AND
each other, with a view to obliging Washington or Beijing to intervene.